eXp Realty Incentivizes Teams To Join With New Equity Incentive

“Thrive” program designed to attract culturally aligned teams

eXp Realty Incentivizes Teams To Join With New Equity Incentive

“Thrive” program designed to attract culturally aligned teams

BELLINGHAM, Wash., Oct. 26, 2023 (GLOBE NEWSWIRE) — eXp Realty®, “the most agent-centric real estate brokerage on the planet™” and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), is excited to announce the launch of its new Thrive program, designed to incentivize culturally aligned, producing teams to join the eXp Realty family.

Once onboarded, the team lead will receive an equity award based on their previous 12-month production, subject to future vesting.

“As a company committed to continuously pushing the boundaries in support of our agents, eXp Realty is always looking for new ways to enhance the agent experience,” said Michael Valdes, Chief Growth Officer, eXp Realty. “Earlier this year, we introduced two incentive programs, Boost and Accelerate, aimed at helping independent brokerages and individual agents transition to eXp Realty. Now with the addition of Thrive, we are offering teams an accelerated equity opportunity. We understand that each team has its own unique culture and way of doing business, and we want to provide a platform for them to thrive in our agent-centric environment.”

eXp Realty will provide this equity incentive to team leads of culturally aligned teams with more than 10 agents in addition to the team lead and a minimum of $40 million (U.S./CAD) in sales volume in the originating country over the previous 12-month fiscal period. International qualifications to be released. Additional qualifications apply. A core criteria of this program is for team leads to commit to team training and ensuring their team members integrate with the eXp Realty ecosystem as part of their cultural alignment with eXp.

The Thrive incentive program is rolling out in the United States and Canada immediately and will soon be available in eXp’s additional 22 global markets, subject to applicable law. To learn more about eXp Realty’s new Thrive program and how it can benefit your team, please click here.

About eXp World Holdings, Inc.

eXp World Holdings, Inc. (Nasdaq: EXPI) is the holding company for eXp Realty®, Virbela® and SUCCESS® Enterprises.

eXp Realty is the largest independent real estate company in the world with more than 89,000 agents in the United States, Canada, the United Kingdom, Australia, South Africa, India, Mexico, Portugal, France, Puerto Rico, Brazil, Italy, Hong Kong, Colombia, Spain, Israel, Panama, Germany, Dominican Republic, Greece, New Zealand, Chile, Poland and Dubai and continues to scale internationally. As a publicly traded company, eXp World Holdings provides real estate professionals the unique opportunity to earn equity awards for production goals and contributions to overall company growth. eXp World Holdings and its businesses offer a full suite of brokerage and real estate tech solutions, including its innovative residential and commercial brokerage model, professional services, collaborative tools and personal development. The cloud-based brokerage is powered by Virbela, an immersive 3D platform that is deeply social and collaborative, enabling agents to be more connected and productive. SUCCESS® Enterprises, anchored by SUCCESS® magazine and its related media properties, was established in 1897 and is a leading personal and professional development brand and publication.

For more information, visit https://expworldholdings.com

Safe Harbor Statement

The statements contained herein may include statements of future expectations and other forward-looking statements that are based on management’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Examples of such forward-looking statements include, but are not limited to, the availability of incentive programs in international markets and the future value of financial incentive programs. Such forward-looking statements speak only as of the date hereof, and the company undertakes no obligation to revise or update them. Such statements are not guarantees of future performance. Important factors that may cause actual results to differ materially and adversely from those expressed in forward-looking statements include changes in business or other market conditions; the difficulty of keeping expense growth at modest levels while increasing revenues; and other risks detailed from time to time in the company’s Securities and Exchange Commission filings, including but not limited to the most recently filed Quarterly Report on Form 10-Q and Annual Report on Form 10-K.

Media Relations Contact:

eXp World Holdings, Inc.
mediarelations@expworldholdings.com

Investor Relations Contact:

Denise Garcia
investors@expworldholdings.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5ef130bf-acbf-422b-a1dc-ae586120d6b8

GlobeNewswire Distribution ID 8966874

KFSH&RC Unveils its Cutting-Edge Approach to Elevating the Patient Treatment Experience at the Global Health Exhibition

KFSH&RC Unveils its Cutting-Edge Approach to Elevating the Patient Treatment Experience

RIYADH, Saudi Arabia, Oct. 26, 2023 (GLOBE NEWSWIRE) — At the 2023 Global Health Exhibition in Riyadh, King Faisal Specialist Hospital and Research Centre (KFSH&RC) is presenting its advanced approach to elevating the patient treatment journey. By harnessing state-of-the-art digital healthcare solutions, the hospital has showcased the role of such tools in enhancing healthcare outcomes and operational efficiency across diverse medical domains.

KFSH&RC has achieved substantial advancements in streamlining the patient admission process through the ‘Ehalat’ service. This automated platform simplifies medical referrals and fosters collaboration with both public and private healthcare entities. Additionally, it empowers users to submit medical reports, compile personal data, and access their medical history—all within a unified service, eliminating the necessity for in-person visits to the hospital. This not only simplifies the evaluation of a patient’s condition and treatment eligibility but also provides real-time tracking and updates on applications.

Patients can now track their treatment progress remotely through “Altakhassusi” mobile application, providing them with secure access to their medical records. The app allows patients to view radiology and medical lab test results, easily schedule appointments, attend virtual follow-up sessions with their physicians, and even assess the effectiveness of their treatment. Moreover, it enhances the process of prescription refills, medical supplies, and nutritional needs, making communication with the medical team and the hospital effortless.

KFSH&RC is dedicated to providing a high-quality treatment experience with automation at every stage. This approach saves time and effort for patients, and it improves medical decision-making through cutting-edge methods and care models that leverage the rapid advancements in digital health innovations. These capabilities enable seamless integration of various medical technologies, consolidating clinical results, documents, and medical data. This ranges from surgical notes to post-operative care, ensuring a smooth flow of information, boosting care efficiency, and customizing it to meet each patient’s unique needs.

KFSH&RC is globally recognized for its exceptional specialized healthcare services and groundbreaking innovations. It stands as an advanced hub for medical research and education, committed to advancing medical technologies and raising the standard of healthcare on a global scale. Through collaborations with prominent local, regional, and international institutions, it aspires to deliver world-class services in clinical care, research, and education.

The Global Health Exhibition, featuring the participation of 250 exhibitors from 15 countries, stands as the premier healthcare gathering in the Middle East. It serves as a platform for collaboration among Saudi and global healthcare communities, including regional and international manufacturers and suppliers. This year’s summit, operating under the theme ‘Investing in Health,’ promises to be a pivotal event shaping the future of healthcare.

Contact information:
kfshrc@mcsaatchi.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2825a442-d3e8-4c08-aa98-61fb48e4fe5e

GlobeNewswire Distribution ID 8966676

KFSH&RC Unveils its Cutting-Edge Approach to Elevating the Patient Treatment Experience at the Global Health Exhibition

KFSH&RC Unveils its Cutting-Edge Approach to Elevating the Patient Treatment Experience

RIYADH, Saudi Arabia, Oct. 26, 2023 (GLOBE NEWSWIRE) — At the 2023 Global Health Exhibition in Riyadh, King Faisal Specialist Hospital and Research Centre (KFSH&RC) is presenting its advanced approach to elevating the patient treatment journey. By harnessing state-of-the-art digital healthcare solutions, the hospital has showcased the role of such tools in enhancing healthcare outcomes and operational efficiency across diverse medical domains.

KFSH&RC has achieved substantial advancements in streamlining the patient admission process through the ‘Ehalat’ service. This automated platform simplifies medical referrals and fosters collaboration with both public and private healthcare entities. Additionally, it empowers users to submit medical reports, compile personal data, and access their medical history—all within a unified service, eliminating the necessity for in-person visits to the hospital. This not only simplifies the evaluation of a patient’s condition and treatment eligibility but also provides real-time tracking and updates on applications.

Patients can now track their treatment progress remotely through “Altakhassusi” mobile application, providing them with secure access to their medical records. The app allows patients to view radiology and medical lab test results, easily schedule appointments, attend virtual follow-up sessions with their physicians, and even assess the effectiveness of their treatment. Moreover, it enhances the process of prescription refills, medical supplies, and nutritional needs, making communication with the medical team and the hospital effortless.

KFSH&RC is dedicated to providing a high-quality treatment experience with automation at every stage. This approach saves time and effort for patients, and it improves medical decision-making through cutting-edge methods and care models that leverage the rapid advancements in digital health innovations. These capabilities enable seamless integration of various medical technologies, consolidating clinical results, documents, and medical data. This ranges from surgical notes to post-operative care, ensuring a smooth flow of information, boosting care efficiency, and customizing it to meet each patient’s unique needs.

KFSH&RC is globally recognized for its exceptional specialized healthcare services and groundbreaking innovations. It stands as an advanced hub for medical research and education, committed to advancing medical technologies and raising the standard of healthcare on a global scale. Through collaborations with prominent local, regional, and international institutions, it aspires to deliver world-class services in clinical care, research, and education.

The Global Health Exhibition, featuring the participation of 250 exhibitors from 15 countries, stands as the premier healthcare gathering in the Middle East. It serves as a platform for collaboration among Saudi and global healthcare communities, including regional and international manufacturers and suppliers. This year’s summit, operating under the theme ‘Investing in Health,’ promises to be a pivotal event shaping the future of healthcare.

Contact information:
kfshrc@mcsaatchi.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2825a442-d3e8-4c08-aa98-61fb48e4fe5e

GlobeNewswire Distribution ID 8966676

Le King Faisal Specialist Hospital & Research Center annonce le lancement d’un service de pharmacogénomique clinique innovant

Une plus grande efficacité des médicaments combinée à une sécurité accrue des patients

RIYADH, Arabie saoudite, 25 oct. 2023 (GLOBE NEWSWIRE) — Le King Faisal Specialist Hospital and Research Centre (« KFSH&RC ») est fier d’annoncer le lancement de la phase inaugurale de son service de pharmacogénomique clinique au sein de son pôle cardiologie. Ce service pionnier utilise l’ADN du patient pour adapter les dosages et le choix des médicaments, annonçant ainsi une nouvelle ère dans les soins de santé, qui donne la priorité à un traitement personnalisé pour chaque individu. Cette approche novatrice devrait permettre d’améliorer les résultats thérapeutiques et de réduire les effets indésirables potentiels des médicaments.

Selon les experts du KFSH&RC, cette analyse permet aux médecins de prescrire des médicaments adaptés à chaque patient, en tenant compte de son état de santé et de ses caractéristiques génétiques. Les réactions des patients aux produits pharmaceutiques peuvent varier considérablement en fonction de leur profil génétique. Par conséquent, ce qui s’avère efficace pour un patient peut n’avoir qu’un effet minime pour un autre. Il convient de noter que les statistiques révèlent que 15 % des admissions à l’hôpital sont dues à des effets indésirables des médicaments, ce qui représente une charge financière et humaine considérable pour les systèmes de soins de santé du monde entier.

Ce service innovant est le fruit d’une collaboration entre le Centre de médecine génomique, le département des technologies de l’information dans le domaine de la santé et le département des soins pharmaceutiques du KFSH&RC. Dans sa phase initiale, ce service englobe six des médicaments les plus fréquemment prescrits, sur la base des données hospitalières recueillies, dont l’efficacité est connue pour être influencée par des variations génétiques.

Le KFSH&RC a clairement indiqué qu’il restait déterminé à étendre progressivement le champ d’application de ce service à tous les services de l’hôpital. Cette expansion souligne la volonté inébranlable de l’hôpital de dispenser des soins de santé personnalisés à chaque patient, de garantir le plus haut niveau de sécurité et de minimiser les effets indésirables, tout en adhérant aux dernières pratiques scientifiques approuvées à l’échelle mondiale.

À l’occasion du salon Global Health Exhibition, qui se tient à Riyad du 29 au 31 octobre, un événement dans le cadre duquel le KFSH&RC joue un rôle essentiel en qualité de partenaire stratégique dans le domaine de la santé, l’hôpital s’apprête à dévoiler ce service innovant qui promet de faire progresser les résultats en matière de soins de santé dans la région.

Le KFSH&RC a déclaré qu’il s’apprêtait à étendre progressivement le champ d’application du service à toutes les spécialités médicales dans le cadre de son engagement à dispenser des soins de santé personnalisés à chaque patient moyennant le plus haut niveau de sécurité et de prévention des effets indésirables et à exploiter les dernières pratiques scientifiquement éprouvées dans le monde entier.

L’établissement est considéré comme l’un des plus réputés au monde en matière de soins de santé spécialisés, un pionnier en matière d’innovation et un centre de recherche et d’enseignement médical de pointe. Il cherche également à développer des technologies médicales et à améliorer les soins de santé dans le monde entier, en partenariat avec d’éminentes institutions locales, régionales et internationales. Assurer un service de niveau international dans les domaines clinique, de la recherche et de l’enseignement, telle est la mission qu’il s’est fixée.

Coordonnées :

kfshrc@mcsaatchi.com

Une photo accompagnant cette annonce est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/9e826983-52ae-4fe5-8579-0cbdfcca9d1c

GlobeNewswire Distribution ID 8965796

King Faisal Specialist Hospital and Research Centre Lança Inovadora Farmacogenômica Clínica

Aprimorando a Eficácia do Medicamento e a Segurança do Paciente

RIADE, Arábia Saudita, Oct. 25, 2023 (GLOBE NEWSWIRE) — O King Faisal Specialist Hospital and Research Centre (KFSH&RC) tem o orgulho de anunciar o lançamento da fase inaugural do seu serviço de farmacogenômica clínica no Heart Center. Este serviço pioneiro que utiliza o DNA do paciente para adaptar as escolhas e dosagens dos medicamentos, estabelece uma nova era na área da saúde que prioriza o tratamento personalizado para cada indivíduo. Esta abordagem inovadora está viabiliza o aprimoramento dos resultados do tratamento e a redução dos danos potenciais.

Os experts da KFSH&RC dizem que esta análise capacita os médicos a prescrever medicamentos personalizados para cada paciente, levando em consideração suas condições de saúde e características genéticas únicas. As respostas dos pacientes aos produtos farmacêuticos podem ser substancialmente diferentes de acordo com seus perfis genéticos. Por isso, o que demonstra ser eficaz para um paciente pode ter um impacto mínimo em outro. Vale a pena notar que as estatísticas revelam que 15% das internações hospitalares decorrem de reações adversas a medicamentos, que causam ônus financeiros e humanos substanciais aos sistemas de saúde em todo o mundo.

Este serviço inovador é um esforço colaborativo entre o Centro de Medicina Genômica, Assuntos de Tecnologia da Informação de Saúde e o Departamento de Assistência Farmacêutica do KFSH&RC. Na sua fase inicial, este serviço engloba seis dos medicamentos mais frequentemente prescritos, de acordo com dados hospitalares, cuja eficácia é sabidamente influenciada pelas variações genéticas.

O KFSH&RC deixou claro que continua empenhado em expandir progressivamente o âmbito deste serviço, abrangendo todos os departamentos do hospital. Essa expansão demonstra a dedicação inabalável do hospital em fornecer cuidados de saúde personalizados a todos os pacientes, garantindo o nível máximo de segurança e minimização de danos, ao mesmo tempo em que adere às mais recentes práticas científicas adotadas em todo o mundo.

Na Exposição Global de Saúde realizada em Riade de 29 a 31 de outubro, onde a KFSH&RC terá um papel vital como parceira estratégica de saúde, o hospital irá introduzir o serviço inovador que promete acelerar os resultados de saúde na região.

O KFSH&RC disse que está trabalhando para expandir gradualmente o escopo da aplicação do serviço para incluir todas as especialidades médicas, como parte do seu compromisso de fornecer cuidados de saúde personalizados para cada paciente no mais alto nível de segurança e prevenção de danos possível, e utilizar as mais recentes práticas cientificamente comprovadas em todo o mundo.

O King Faisal Specialist Hospital and Research Center é considerado um dos mais proeminentes do mundo na prestação de cuidados de saúde especializados, um pioneiro em inovação e um centro avançado de pesquisa e educação médica. O hospital também trabalha no desenvolvimento tecnologias médicas e aprimoramento dos cuidados de saúde em todo o mundo em parceria com instituições locais, regionais e internacionais proeminentes. Para o alcance de um serviço de classe mundial nos campos clínico, de pesquisa e educacional.

Informações de Contato:

kfshrc@mcsaatchi.com

Foto deste comunicado disponível em https://www.globenewswire.com/NewsRoom/AttachmentNg/9e826983-52ae-4fe5-8579-0cbdfcca9d1c

GlobeNewswire Distribution ID 8965796